Philip has more than 20 years' experience writing about companies, general finance and investing matters for a variety of publications. His career has involved spells at the Investors Chronicle, where he was small companies and companies editor, Investors Week and most recently as editor of online financial news wire Sharecast. He has also contributed to a wide range of financial-focused publications on a freelance basis.
Huanzhong Biotech and Wanma Technology have both signed 3-year exclusive distribution agreements
“This work has the potential to uncover a whole new area in cancer therapeutics"
The urgency and size of the market offers huge potential for any company that can come up with a new way to treat infections safely
The better-than-expected outcome reflects a trebling in the share price of Immupharma
The event was attended by 16,500 ingredient buyers and suppliers from the supplement, beverage, functional food, personal care and sports nutrition industries
The US-based study will target refractory or non-responsive patients
The five year research project will look at ways to extract proteins from food processing residues
The contract value is £1.2mln over a three year term
In a £1bn deal, won against five other tenders, Morrison's will supply Safeway products and other national brands to 1,300 McColl's stores and 350 newsagents
British Telecom is developing a habit for unpleasant surprises
Brokers see price parity between electric and non –electric vehicles as early as next year
Who would have thought electronic payments systems were so valuable?